Allwinnertech Technology Co.Ltd(300458) performance express: net profit in 2021 increased by 141.48% year-on-year
Allwinnertech Technology Co.Ltd(300458) (300458) released the performance express on February 18. The operating revenue in 2021 was 2.065 billion yuan, a year-on-year increase of 37.19%; The net profit was 494 million yuan, a year-on-year increase of 141.48%; The basic earnings per share is 1.5 yuan. During the reporting period, benefiting from the strong demand for intelligent hardware, intelligent vehicle and codec product lines, the company’s revenue increased year-on-year, and the growth of revenue and gross profit margin promoted the growth of net profit.
Joincare Pharmaceutical Group Industry Co.Ltd(600380) : more than 10 high-quality and high-yield / potential high-yield strains have been applied in production
According to a survey conducted by Joincare Pharmaceutical Group Industry Co.Ltd(600380) (600380), the company’s Henan Joincare Pharmaceutical Group Industry Co.Ltd(600380) biomedical research institute has successively established six R & D platforms, including industrial strain breeding, synthetic biology, biocatalysis, fermentation amplification, product extraction and biochemical API. The Institute is making every effort to tackle the transformation and upgrading of production strains of cephalosporin C and phenylalanine. At present, more than 10 strains of high-quality and high-yield / potential high-yield strains have been applied in production. The company is confident to further reduce the total cost of cephalosporin C and phenylalanine. The cost reduction is mainly reflected in the improvement of unit output capacity on the premise of specific / fixed production factors (regardless of price increase).
Zhejiang Dehong Automotive Electronic & Electrical Co.Ltd(603701) : it is proposed to acquire 60% equity
Zhejiang Dehong Automotive Electronic & Electrical Co.Ltd(603701) (603701) announced on February 18 that it plans to acquire 60% equity of Chongqing Pulian Zhongli Auto Parts Co., Ltd. (hereinafter referred to as “Pulian Zhongli”) held by Chen Feiying, Wang Maoqiang and Chongqing youyuezhixing Enterprise Management Co., Ltd. for 63 million yuan. After the transaction, Pulian Zhongli will become the holding subsidiary of the company, It will significantly accelerate the market development and layout of the company’s electronic vacuum pump products in the field of new energy vehicles.
Guangdong Orient Zirconic Ind Sci And Tech Co.Ltd(002167) : the sales price of zirconium products will be raised from February 18
Guangdong Orient Zirconic Ind Sci And Tech Co.Ltd(002167) (002167) announced on February 18 that the sales price of relevant zirconium products will be increased from February 18, zirconium oxychloride products (including mother liquor) will be increased by 1000 yuan / ton, and zirconium dioxide products will be increased by 3000 yuan / ton. At the same time, the prices of other zirconium series products of the company will be adjusted simultaneously. The increase in product sales price will have a positive impact on the company’s operating performance.
Zhejiang Anglikang Pharmaceutical Co.Ltd(002940) : it is proposed to transfer 15.74% shares of Kerui biology for RMB 157 million
Zhejiang Anglikang Pharmaceutical Co.Ltd(002940) (002940) announced on February 18 that the company plans to transfer 15.74% shares of Kerui Biology (832780) held by Hainan Shengjian with RMB 157 million by agreement. After the completion of the transaction, the company will hold 18.65% shares of Kerui biology in total. Kerui biology is mainly engaged in pharmaceutical intermediates. The company purchased the equity of Kerui biology based on its recognition of its development potential.
Shanxi C&Y Pharmaceutical Group Co.Ltd(300254) : the material entity entrusted by the holding subsidiary to produce covid-19 generic drugs
Shanxi C&Y Pharmaceutical Group Co.Ltd(300254) (300254) announced on February 18 that Jiayi pharmaceutical, the holding subsidiary of the company, signed the entrusted processing cooperation agreement with Laos United Pharmaceutical Co., Ltd. to entrust Jiayi pharmaceutical to produce molnupivir generic anti-covid-19 drug.
Zotye Automobile Co.Ltd(000980) : no strategic agreement has been signed with Great Wall Motor Company Limited(601633)
Zotye Automobile Co.Ltd(000980) (000980) issued a Clarification Announcement on February 18, saying that some media recently released reports on Great Wall Motor Company Limited(601633) swallowing Zhongtai and acquiring Zhongtai Linyi factory. After verification, neither the company nor its subordinate Jiangnan Linyi Branch nor zhuotai automobile sales company has signed any strategic agreement with Great Wall Motor Company Limited(601633) . The above two companies under the company have stopped production and shut down for a long time, and the subsequent disposal of the assets of the two companies has not been determined yet.
